Revisiting the role of dose escalation in esophageal cancer in the era of modern radiation delivery
- PMID: 32395301
- PMCID: PMC7212128
- DOI: 10.21037/jtd.2020.02.38
Revisiting the role of dose escalation in esophageal cancer in the era of modern radiation delivery
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/jtd.2020.02.38). The authors have no conflicts of interest to declare.
Comment on
-
Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer.JAMA Oncol. 2019 Nov 1;5(11):1597-1604. doi: 10.1001/jamaoncol.2019.2809. JAMA Oncol. 2019. PMID: 31529018 Free PMC article. Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources